Cerevel Therapeutics

Neumora Therapeutics

This biopharmaceutical company develops medicines for patients with neuropsychiatric disorders and neurodegenerative diseases.

MapLight Therapeutics

This company develops targeted therapeutics for patients with brain disorders including schizophrenia, autism spectrum disorder and Parkinson’s disease.

Newron

This biopharmaceutical company develops and commercialises therapies for patients with central and peripheral nervous system disorders, such as schizophrenia and Parkinson's disease.

Cyclerion Therapeutics

This biopharmaceutical company develops neuropsychiatric therapies for patients with treatment-resistant depression and other neurodegenerative diseases.

Alkermes

This biopharmaceutical company develops and manufactures neuroscience medicines for patients with schizophrenia, bipolar I disorder, and alcohol or opioid dependence.

Syremis Therapeutics

This biopharmaceutical company develops small-molecule oral medicines for patients with neuropsychiatric conditions, including schizophrenia, major depressive disorder and bipolar depression.

Arvelle Therapeutics

This biopharmaceutical company develops and commercialises antiepileptic medicines to treat patients suffering from central nervous system disorders.

Cerevance

This pharmaceutical company develops therapies for neurodegenerative diseases and central nervous system disorders for patients and healthcare providers.